Yaniv Dolev

Moebius Medical Ltd. develops mechanical lubricants for reducing joint damage. It develops MM-II, a novel liposome-based bio-lubricant for long-term treatment of osteoarthritis. The company was founded by Yaniv Dolev and Yechezkel Barenholz in 2008 and is headquartered in Tel Aviv, Israel.

Cody Genetics Ltd. is a British animal biotechnology company that applies gene-editing technology to benefit animal farming. Cody Genetics is based in Edinburgh, UK and was founded in 2022 by Yaniv Dolev, who has been the CEO since inception, and Glen Illing, who is the founder and chairman. The company is committed to becoming a leader in the farm animal gene-editing industry through its collaborations with leading academic and industry research institutes. The company's first product is sex-biasing in farm animals, which increases profitability, quadruples semen yield, lowers costs 20x +, increases successful inseminations, decreases production waste and environmental impact, eliminates culling of 3.5b male chicks, reduces breeding hens by 50%, and eliminates swine castration while improving efficiency of production. Cody Genetics is currently raising capital and has partnered with industry leaders.

Moebius Medical Ltd. develops mechanical lubricants for reducing joint damage. It develops MM-II, a novel liposome-based bio-lubricant for long-term treatment of osteoarthritis. The company was founded by Yaniv Dolev and Yechezkel Barenholz in 2008 and is headquartered in Tel Aviv, Israel.